TrialAllergy2022

Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.

Montserrat Fernandez-Rivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.